Clinical and Imaging Prognosis in Patients with Delayed Encephalopathy after Acute Carbon Monoxide Poisoning | Canada Hyperbarics Skip to main content
Review Behav Neurol 2020

Clinical and Imaging Prognosis in Patients with Delayed Encephalopathy after Acute Carbon Monoxide Poisoning

Liu J, Si Z, Liu J, Lin Y, Yuan J, Xu S, et al. — Behav Neurol, 2020

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reviewed the medical records of 20 patients who developed delayed brain problems after experiencing carbon monoxide poisoning.

What They Found

Patients showed diverse symptoms including memory deficits and personality changes, with MRI scans revealing lesions in the brain's white matter or basal ganglia. After treatment, including hyperbaric oxygen, cognitive impairment decreased from 95% to 25% and psychiatric symptoms dropped from 95% to 55% at the six-month follow-up. However, the overall prognosis for these patients was poor, with many experiencing severe disability.

Canadian Relevance

This study covers carbon monoxide poisoning, which is a Health Canada-recognised indication for hyperbaric oxygen therapy. No direct Canadian connection was identified regarding authors or study location.

Study Limitations

The study was limited by its small sample size of 20 patients and its retrospective design, which involved reviewing past medical records.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Review
Category Neurological
Source Pubmed
PubMed ID 33376556
Year Published 2020
Journal Behav Neurol
MeSH Terms Brain Diseases; Carbon Monoxide Poisoning; Humans; Magnetic Resonance Imaging; Prognosis; Retrospective Studies

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 16, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology